首页> 外国专利> Method for increasing specific deletion mediated by the endogenous immune response of the population of pathogenic cells in a host animal immunized previously, Composition and combination comprising an Auxiliary and A hapten Carrier conjugate Th1 - used in the same.

Method for increasing specific deletion mediated by the endogenous immune response of the population of pathogenic cells in a host animal immunized previously, Composition and combination comprising an Auxiliary and A hapten Carrier conjugate Th1 - used in the same.

机译:在先前免疫的宿主动物中增加由病原细胞群体的内源性免疫应答介导的特异性缺失的方法,其中使用了包含辅助和半抗原载体缀合物Th1-的组合物和组合。

摘要

A method of eliminating pathological cells in host The basis of this method is to improve the understanding of the host immune system, and to deal with the number of pathogenic cells by improving the disease resistance of the pathogenic cells, so as to strengthen the elimination of the endogenous immune response of the population of pathogenic cells. According to this method, immunoconjugation or hapteno conjugation is managed to the host to bind to the surface of tumor cells or pathological organisms, while the conjugation uses immuno or hapteno to label the cells of the target cell group,As a result, people with labeled cells are immunized. The presence or production of antibodies in the host body combines with immunogens or hafteno, leading to endogenous immune response. In the case of alternation, immune cells or hapteno can be directly recognized in the host. The improvement of this method includes the use of an assistant for Th1 separation to enhance the response to immunogen / hapteno. This method includes the use of an immune pair or a pair hafteno symbiont, characterized by ligation that specifically binds to a live pathogenic cell population,However, the binding of immunogen / hapteno can be recognized by antibodies or directly by host immune cells. Hapteno was selected from the tin fluoride and dinitrophenyl groups.
机译:一种消除宿主病理细胞的方法该方法的基础是增进对宿主免疫系统的了解,并通过提高病原细胞的抗病性来处理病原细胞的数量,从而加强对病原细胞的清除。病原细胞群体的内源性免疫反应。按照这种方法,免疫结合或人参结合被控制在宿主上以结合到肿瘤细胞或病理生物的表面,而结合则使用免疫或人参结合来标记目标细胞群的细胞,结果,被标记的人细胞被免疫。抗体在宿主体内的存在或产生会与免疫原或蜂毒结合,导致内源性免疫反应。在交替的情况下,免疫细胞或hepteno可以直接在宿主中识别。该方法的改进包括使用辅助剂进行Th1分离,以增强对免疫原/人参的反应。该方法包括使用免疫对或人参共生体对,其特征在于连接后可特异性结合至活的病原体细胞群。然而,免疫原/ hapteno的结合可被抗体识别或直接被宿主免疫细胞识别。 Hapteno选自氟化锡和二硝基苯基。

著录项

  • 公开/公告号AR039429A1

    专利类型

  • 公开/公告日2005-02-16

    原文格式PDF

  • 申请/专利权人 ENDOCYTE INC.;

    申请/专利号AR2003P101333

  • 发明设计人 LU YINGJUAN;

    申请日2003-04-16

  • 分类号A61K38/19;A61K38/20;A61K31/525;A61K31/352;A61P35/00;

  • 国家 AR

  • 入库时间 2022-08-21 22:18:52

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号